TY - JOUR
T1 - Clinical significance of EGFR, Her-2 and EGF in oral squamous cell carcinoma
T2 - A case control study
AU - Bernardes, Vanessa F.
AU - Gleber-Netto, Frederico O.
AU - Sousa, Sílvia F.
AU - Silva, Tarcília A.
AU - Aguiar, Maria Cássia F.
N1 - Publisher Copyright:
© 2010 Bernardes et al.
PY - 2010/4/29
Y1 - 2010/4/29
N2 - Background: The ERBB receptors and their ligands are involved in the pathogenesis and progression of oral squamous cell carcinoma (OSCC). Although EGFR and Her-2 are frequently overexpressed in OSCC, few studies evaluated these proteins in saliva and their association with the tumor, which may represent potential usefulness in a clinical setting. Methods: The levels of EGFR, Her-2, and EGF were evaluated in saliva of 46 patients with OSCC before and after the surgical removal of the lesion, as well as in matched healthy controls. The relationship of salivary levels and EGFR and Her-2 immunoexpression in tumor samples with clinicopathological features was analyzed. Results: EGFR and Her-2 salivary levels did not show difference between to pre-surgery and control groups, however, both demonstrated an increase after surgical removal of the tumor. No association was detectable among receptor salivary levels, tissue expression and clinicopathological features. EGF levels in pre-surgery group were significantly lower when compared to the control group. Conclusions: EGFR and Her-2 were not considered to be valuable salivary tumor markers in OSCC, however, lower levels of EGF in saliva may suggest a higher susceptibility for OSCC development.
AB - Background: The ERBB receptors and their ligands are involved in the pathogenesis and progression of oral squamous cell carcinoma (OSCC). Although EGFR and Her-2 are frequently overexpressed in OSCC, few studies evaluated these proteins in saliva and their association with the tumor, which may represent potential usefulness in a clinical setting. Methods: The levels of EGFR, Her-2, and EGF were evaluated in saliva of 46 patients with OSCC before and after the surgical removal of the lesion, as well as in matched healthy controls. The relationship of salivary levels and EGFR and Her-2 immunoexpression in tumor samples with clinicopathological features was analyzed. Results: EGFR and Her-2 salivary levels did not show difference between to pre-surgery and control groups, however, both demonstrated an increase after surgical removal of the tumor. No association was detectable among receptor salivary levels, tissue expression and clinicopathological features. EGF levels in pre-surgery group were significantly lower when compared to the control group. Conclusions: EGFR and Her-2 were not considered to be valuable salivary tumor markers in OSCC, however, lower levels of EGF in saliva may suggest a higher susceptibility for OSCC development.
UR - http://www.scopus.com/inward/record.url?scp=77951592932&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77951592932&partnerID=8YFLogxK
U2 - 10.1186/1756-9966-29-40
DO - 10.1186/1756-9966-29-40
M3 - Article
C2 - 20429940
AN - SCOPUS:77951592932
SN - 0392-9078
VL - 29
JO - Journal of Experimental and Clinical Cancer Research
JF - Journal of Experimental and Clinical Cancer Research
IS - 1
M1 - 40
ER -